medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2006, Number 03

<< Back Next >>

Ginecol Obstet Mex 2006; 74 (03)

Ofuji’s diseases and pregnancy. A report of a case

Gutiérrez GHI, Carrillo IMJ, Pestaña MS, Santamaría FM

Language: Spanish
References: 26
Page: 158-163
PDF size: 321.76 Kb.


ABSTRACT

Eosinophilic pustular folliculitis, which was first described by Ofuji, is a type of dermatosis characterized by pruritic, follicular, papules and pustules that gradually extend peripherally and have central tendency. Ofuji’s disease has been rarely reported, and has not been reported in pregnancy. It’s possible that hypersensitivity reaction plays an important role. There is no consensus on treatment approaches. We present the case of a 27 year-old woman during the 12.5 weeks of her first pregnancy; she had developed Ofuji’s disease for 17 years. Previously, she had been treated with corticosteroid and azatioprine for 15 years, which were suspended by the time she was diagnosed with pregnancy. Then, she was referred to our maternal fetal medicine department, and was treated with prednisone 25 mg a day. The patient had urinary infection and vulvovaginitis at the week 14.2, with peripheral blood eosinophilia. She had exacerbations at the weeks 35.2 and 38.1, which were treated only with prednisone and topical management; furthermore she had a total of 4 kg of weight gain during the whole pregnancy. Cesarean delivery was performed for nonreassuring fetal heart rate. Perinatal results were: woman with lower birth weight: 2,450 g, Apgar 5.8, placenta with calcifications on 60% of it and single nuchal cord. She had exacerbations in late puerperium. A healthy newborn was obtained and no clinical findings of dermatoses were found. Maternal autoimmune diseases may induce remission or exacerbation during pregnancy. Nevertheless, in this case the induced exacerbations during puerperium and the fact that a low birth weight was obtained are problems commonly associated with the prolonged use of corticosteroids during pregnancy.


REFERENCES

  1. Ishiguro N, Shishido E, Okamoto, et al. Ofuji’s disease: a report on 20 patients with clinical and histopathologic analysis. J Am Acad Dermatol 2002;46(6):827-33.

  2. Basarab T, Jones R. HIV-associated eosinophilic folliculitis: case report and review of the literature. Br J Dermatol 1996;21(1):67-71.

  3. Hayes B, Hille R, Goldberg L. Eosinophilic folliculitis in 2 HIV positive women. Arch Dermatol 2004;140:463-5.

  4. Ho MH, Chong LY, Ho TT. HIV associated eosinophilic folliculitis in a Chinese woman: a case report and survey in Hong Kong. Int J STD AIDS 1998;9(8):489-93.

  5. Tang MB, Tan E. Eosinophilic pustular folliculitis. Aust J Dermatol 2003;44(1):44-47.

  6. Selim MA. Eosinophilic folliculitis. emedicine.com

  7. Ellis E, Scheinfeld N. Eosinophilic pustular folliculitis. A comprehensive review of treatment options. Am J Clin Dermatol 2004;5(3):189-97.

  8. Retamal R, Chames C. Enfermedades eosinofílicas cutáneas. Educación médica continua. Publicación de la Sociedad Argentina de Dermatología 2002;7(4):

  9. Simpson Sl, Fearfield LA. HIV associated eosinophilic folliculitis-differential diagnosis and management sexually transmitted infections. 1999;75(5):291-3.

  10. Arpaia N, Laricchia F, Cassano N. Infantile eosinophilic folliculitis: a case report. Pediatr Dermatol 2000;17(5):426.

  11. Idoate M, Iglesias M, Quintanilla E. Are eosinophilic pustular folliculitis of infancy and infantile acropostulosis the same entity? Pediatr Dermatol 1997;14(3):253.

  12. Larralde M. Eosinophilic pustular folliculitis in infancy: report of two new cases. Pediatr Dermatol 1999;16(2):118-20.

  13. Miura H, Shoda Y, Adachi J. Eosinophilic pustular folliculitis in infancy in a Japanese neonate. Pediatr Dermatol 2004;21:615-6.

  14. Boone M, Dangoisse C, Andre J, Song M. Eosinophilic pustular folliculitis in atopic children with hypersensitivity to Dermatophagoides Pteronyssinus. Pediatr Dermatol 1996;13(2):179.

  15. Miyuki I, Hayakawa J, Shiohara J. Japan HIV seronegative eosinophilic pustular folliculitis successfully treated with metronidazole. J Am Acad Dermatol 2002;46:153-5.

  16. Mi-Woo L, Deuk-Pyo L, Jee-Ho C, et al. Failure to detect clonality in eosinophilic pustular folliculitis with follicular mucinosis. Acta Derm Venereol 2004;84:305-7.

  17. Hsu PJ, Huang CJ, Wu MT. Pathergy in atypical eosinophilic pustular folliculitis. Int J Dermatol 2005;44:203-5.

  18. Dupond AS, Aubin F, Bourezane Y, et al. Eosinophilic pustular folliculitis in infancy: report of two affected brothers. Pediatr Dermatol 1996;13(3):266.

  19. Fushimi M, Tokura Y, Sachy Y, Hashizume H. Eosinophilic pustular folliculitis effectively treated with recombinant interferon-gamma: suppression of mRNA expression of interleukin 5 in peripheral blood mononuclear cells. Br J Dermatol 1996;134(4):766-72.

  20. Buckley D. Neonatal eosinophilic pustular folliculitis. Clin Exp Dermatol 2001;26(3):251-5.

  21. Youn C. Eosinophilic pustular folliculitis treated with naproxen. Br J Dermatol 2001;145(3):514-5.

  22. Rogers M. Successful treatment of eosinophilic pustulosis with oral cimetidine. Pediatr Dermatol 1999;16(4):335-6.

  23. Ota t, Hata Y, Tanikawa A. Eosinophilic pustular folliculitis (Ofuji’s disease): indomethacin as a first choice of treatment. Clin Exp Dermatol 2001;26(2):179-81.

  24. Masakazu K, Yoshihiko M, Shigeo K. Successful treatment of eosinophilic pustular folliculitis with topical tacrolimus. Int J Dermatol 2004;43:608-10.

  25. Ahued AJR, Fernández del Castillo SC , Bailón U. Ginecología y Obstetricia Aplicadas. 2a ed. México: El Manual Moderno, 2003;pp:555.

  26. Kroumpouzos G, Cohen M. Dermatoses of pregnancy. Continuing medical education. J Am Acad Dermatol 2001;45:1-19.




2020     |     www.medigraphic.com